Palvella Therapeutics, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Jarvis is thinking

Palvella Therapeutics, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Income Statement

	2025-12-31	2024-12-31
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$38.60M	-$14.10M
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$41.70M	-$17.40M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-3.00	$-7.83
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-3.00	$-7.83

Balance Sheet

	2025-12-31	2024-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$57.98M	$83.60M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$59.56M	$88.23M
Everything the company owes — debt, unpaid bills, and other obligations.	$31.58M	$25.63M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$27.98M	$62.61M

Cash Flow Statement

	2025-12-31	2024-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$25.00M	-$10.80M